Last Updated 1 March 2021.
3 Vaccines Approved for Use in Brazil
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 67 countries
11 trials in 9 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 58 countries
22 trials in 13 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 13 countries
11 trials in 5 countries
6 Vaccines in Clinical Trials in Brazil
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 10 countries
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 67 countries
11 trials in 9 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 other countries
6 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 58 countries
22 trials in 13 countries
-
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 13 countries
11 trials in 5 countries